Two Sigma Securities, LLC Inovio Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.35 - $0.53 $6,313 - $9,560	18,039 Added 19.95%	108,455 $55,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $8,653 - $13,207	-22,772 Reduced 20.12%	90,416 $35,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $44,143 - $106,396	113,188 New	113,188 $50,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $31,805 - $56,392	22,557 New	22,557 $35,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $33,557 - $92,749	23,304 Added 87.1%	50,060 $87,000
Q1 2022 May 16, 2022	BUY	$2.97 - $5.2 $79,465 - $139,131	26,756 New	26,756 $96,000
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $106,969 - $172,215	-17,170 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $151,267 - $291,203	17,170 New	17,170 $159,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.